| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/24/2011 | US20110046148 Spirocyclic Heterocycles Medicaments Containing Said Compounds, Use Thereof And Method For Their Production |
| 02/24/2011 | US20110046147 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases |
| 02/24/2011 | US20110046146 Phosphodiesterase 4 inhibitors |
| 02/24/2011 | US20110046145 Quinolizidinone M1 Receptor Positive Allosteric Modulators |
| 02/24/2011 | US20110046144 Imidazopyrazinol derivatives for the treatment of cancers |
| 02/24/2011 | US20110046143 Disubstituted phthalazine hedgehog pathway antagonists |
| 02/24/2011 | US20110046142 Antibiotic compounds |
| 02/24/2011 | US20110046141 Use of pde5 inhibitors for treating circadian rhythm disorders |
| 02/24/2011 | US20110046139 Benzocycloheptane and benzoxepine derivatives |
| 02/24/2011 | US20110046138 Novel compounds advantageous in the treatment of central nervous system diseases and disorders |
| 02/24/2011 | US20110046137 Pyrazole Derivatives as P2X7 Modulators |
| 02/24/2011 | US20110046136 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associcated therewith |
| 02/24/2011 | US20110046135 New compounds i |
| 02/24/2011 | US20110046134 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE |
| 02/24/2011 | US20110046133 Organic compounds |
| 02/24/2011 | US20110046132 Benzoimidazoles as prolyl hydroxylase inhibitors |
| 02/24/2011 | US20110046131 Purines as pkc-theta inhibitors |
| 02/24/2011 | US20110046130 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists |
| 02/24/2011 | US20110046129 2-Phenylethylamino Derivatives as Calcium and/or Sodium Channel Modulators |
| 02/24/2011 | US20110046128 Novel compounds advantageous in the treatment of central nervous system diseases and disorders |
| 02/24/2011 | US20110046127 Imidazopyridazines for Use as Protein Kinase Inhibitors |
| 02/24/2011 | US20110046126 Use of 2,4-Pyrimidinediamines For the Treatment of Atherosclerosis |
| 02/24/2011 | US20110046125 Method for treating infections |
| 02/24/2011 | US20110046122 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines |
| 02/24/2011 | US20110046121 Inhibitors of focal adhesion kinase |
| 02/24/2011 | US20110046120 Treatment of impulse control disorders |
| 02/24/2011 | US20110046119 Therapeutic treatment |
| 02/24/2011 | US20110046118 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
| 02/24/2011 | US20110046117 Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditions |
| 02/24/2011 | US20110046116 Sedative for use during eye surgery |
| 02/24/2011 | US20110046115 Mirtazapine Solid Dosage Forms |
| 02/24/2011 | US20110046114 Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 02/24/2011 | US20110046113 Amine compound and use thereof |
| 02/24/2011 | US20110046112 Novel bicyclic sulfonamide derivatives which are l-cpt1 inhibitors |
| 02/24/2011 | US20110046111 Quinazoline linked pyrrolo[2,1-c][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof |
| 02/24/2011 | US20110046110 Quinolines and related analogs as sirtuin modulators |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046108 Pyrimidine derivatives |
| 02/24/2011 | US20110046107 Sulfonyl-substituted carbapenem compounds |
| 02/24/2011 | US20110046106 Aryl sulfonamides as effective analgesics |
| 02/24/2011 | US20110046105 Heterocycle-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising them and use thereof |
| 02/24/2011 | US20110046104 Aminopyrimidines useful as kinase inhibitors |
| 02/24/2011 | US20110046103 Neurotherapeutic Cephalosporin Sulfoxide and Sulfone-Containing Compositions |
| 02/24/2011 | US20110046102 Azabicyclic compounds, preparation thereof and use of same as drugs, especially beta-lactamase inhibitors |
| 02/24/2011 | US20110046101 Bate-lactamase inhibitors |
| 02/24/2011 | US20110046100 Texaphyrin solutions and pharmaceutical formulations |
| 02/24/2011 | US20110046099 Steroid hormone products and methods for preparing them |
| 02/24/2011 | US20110046098 Progesterone antagonists such as cdb-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer, etc. |
| 02/24/2011 | US20110046097 Substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 02/24/2011 | US20110046096 Novel piperazino-dihydrothienopyrimidine derivatives |
| 02/24/2011 | US20110046095 Steroid hormone products and methods for preparing them |
| 02/24/2011 | US20110046094 Methods and compositions for identifying and treating lupus |
| 02/24/2011 | US20110046093 Pyrimidine derivatives as protein kinase inhibitors |
| 02/24/2011 | US20110046092 Small molecules for neuronal differentiation of embryonic stem cells |
| 02/24/2011 | US20110046091 Composition and methods used during anti-hiv treatment |
| 02/24/2011 | US20110046090 Modulation of neurogenesis with gaba agents and gaba analogs |
| 02/24/2011 | US20110046089 Substituted 2-phenyl-pyridine derivatives |
| 02/24/2011 | US20110046087 Pharmaceutical composition, methods for treating and uses thereof |
| 02/24/2011 | US20110046086 Composition Comprising Polysaccharide Extracted from Panax Ginseng Preventing and Treating Liver Diseases |
| 02/24/2011 | US20110046085 Oral Immunostimulation of Fish from (1-4) Linked Beta-D-Mannuronic Acid |
| 02/24/2011 | US20110046084 Exopolysaccharide |
| 02/24/2011 | US20110046083 Activators of pyruvate kinase m2 and methods of treating disease |
| 02/24/2011 | US20110046082 Deuterium-enriched nelarabine |
| 02/24/2011 | US20110046081 Classical cannabinoid metabolites and methods of use thereof |
| 02/24/2011 | US20110046080 Composition for Treating a Skin Disorder |
| 02/24/2011 | US20110046079 Use of Proton Pump Inhibitors as Drug Delivery Adjuvants |
| 02/24/2011 | US20110046078 Methods and compositions for treating diseases and disorders associated with siglec-8 |
| 02/24/2011 | US20110046077 Process for the extraction of mangiferin and isomangiferin |
| 02/24/2011 | US20110046076 Pharmaceutical composition, methods for treating and uses thereof |
| 02/24/2011 | US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 02/24/2011 | US20110046067 COMPOSITIONS COMPRISING HUMAN EGFR-siRNA AND METHODS OF USE |
| 02/24/2011 | US20110046064 Methods and compositions using selective delta opioid receptor-1 agonists, delta opioid receptor-2 antagonists, and/or mu opioid receptor antagonists for treatment of substance-related disorders |
| 02/24/2011 | US20110046050 Phenylalkylcarboxylic acid delivery agents |
| 02/24/2011 | US20110046042 Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use Thereof |
| 02/24/2011 | US20110045983 Gel composition |
| 02/24/2011 | US20110045589 Methods Of Controlling Proliferation And Differentiation Of Stem And Progenitor Cells |
| 02/24/2011 | US20110045481 Methods and compositions for the assessment of drug response |
| 02/24/2011 | US20110045110 Nutritional Compositions Containing Punicalagins |
| 02/24/2011 | US20110045107 Dietary Supplement and Method for the Treatment of Digestive Tract Ulcers in Equines |
| 02/24/2011 | US20110045102 Cancer chemotherapy compositions comprising PI3K pathway modulators and triptolide |
| 02/24/2011 | US20110045100 Antimalarial Quinolines and Methods of Use Thereof |
| 02/24/2011 | US20110045097 Solid pharmaceutical composition comprising irbesartan |
| 02/24/2011 | US20110045096 Solubilized delivery system for topical anesthetics |
| 02/24/2011 | US20110045092 Casein particles encapsulating therapeutically active agents and uses thereof |
| 02/24/2011 | US20110045090 Formulations of flibanserin |
| 02/24/2011 | US20110045089 Vitamin k3 derivative / nsa formulation |
| 02/24/2011 | US20110045088 Intranasal granisetron and nasal applicator |
| 02/24/2011 | US20110045086 Steroid Nebuliser Formulation |
| 02/24/2011 | US20110045085 Process for obtaining powder compositions of orlistat |
| 02/24/2011 | US20110045082 Agglomerates by crystallisation |
| 02/24/2011 | US20110045080 Single-Walled Carbon Nanotube/Bioactive Substance Complexes and Methods Related Thereto |
| 02/24/2011 | US20110045076 Linear order release polymer |
| 02/24/2011 | US20110045075 Tissue coating for preventing undesired tissue-to-tissue adhesions |
| 02/24/2011 | US20110045074 Matrix type sustained-release preparation containing basic drug or salt thereof and, method for manufacturing the same |
| 02/24/2011 | US20110045073 Methods and compositions of sphingolipid for preventing and treating microbial infections |
| 02/24/2011 | US20110045070 Combination therapy |
| 02/24/2011 | US20110045069 Precursor compounds of sweet taste receptor antagonists for the prevention or treatment of disease |
| 02/24/2011 | US20110045068 Pharmaceutical formulations for the oral administration of ppi |
| 02/24/2011 | US20110045066 Pharmaceutical compound containing silymarin and carbopol, its manufacturing process and its use as a regenerator of the pancreatic tissue and cells of endogenous secretion damaged by diabetes mellitus |
| 02/24/2011 | US20110045065 Substance having antioxidant, geroprotective and anti-ischemic activity and method for the preparation thereof |